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INTRODUCTION
Uterine fibroids or leiomyoma arise from smooth muscle
cells of the uterine myometrium. As other leiomyoma, they are
benign, but may lead to excessive menstrual bleeding (men-
orrhagia), often cause anemia and may lead to infertility (1).
Both the economic cost and the effect of uterine leiomyoma on
quality of life are substantial. Progression through the mam-
malian cell cycle is regulated by cyclins, cyclin-dependent
kinases (CDKs), and cyclin-dependent kinase inhibitors (CKIs).
The function of these proteins in the irreversible growth arrest
associated with terminally differentiated cells is largely un-
known. p27Kip1 (p27) is a CKI whose specific late G1 destruc-
tion allows progression of the cell across the G1/S boundary.
The protein is ubiquitinated by S-phase kinase-interacting
protein-2 (Skp2) following its specific phosphorylation, and
is subsequently degraded by the 26s proteosome (2). There
is a direct relationship between low level of p27 and rapid
proliferation occurring in several benign states and in many
malignancies. It has been reported that p27 levels are marked-
ly reduced in several malignancies, such as those of the skin
(3), hepatic (4), bladder (5), thyroid (6), breast (7), prostate
(8) and endometrium (9). In some of the tumors studied, a
strong correlation has been found between the low level of
p27, the aggressiveness of the disease and poor prognosis of
the patients (7). Interestingly, p27 in all these tumors is of
the wild-type species, and its deregulation has been attribut-
ed to aberrant accelerated ubiquitin-mediated degradation of
the protein. Expression of p27 in certain tissues is regulated
by hormones, as in the case of endometrial tissue where the level
of p27 is hormone-dependent. Estrogen exposure has been
considered as an important risk factor in developing endome-
trial cancer (10). Up-regulation of p27 by progesterone has
been demonstrated in glandular cells (11).
Although many studies have suggested that genetic and
epigenetic factors play a role in the progression of uterine lei-
omyoma via oncogene activation or tumor suppressor gene
inactivation, the potent gatekeeper in uterine leiomyoma devel-
opment and progression remains unclear. Recent progress in
molecular biology techniques has revealed that deregulation
of the cell cycle machinery is deeply involved in many types
of cancer cells (12). Histological (13, 14) and gene expression
profiling studies (15) have shown differential expression of
p27 in uterine leiomyoma. Nevertheless, though historically
thought of as antiproliferative, a number of recent studies have
shown that p21 and p27 can assume both pro- and anti-apop-
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Cyclin-Dependent Kinase Inhibitor p27
Kip1 Controls Growth and Cell
Cycle Progression in Human Uterine Leiomyoma
The molecular mechanism of the cell-cycle machinery in uterine leiomyoma has not
yet been fully elucidated. Among the various types of cell-cycle regulators, p27
Kip1
(p27) is considered to be a potent tumor suppressor. To provide further molecular
basis for understanding the progression of uterine leiomyoma, our objective was to
evaluate the expression level of p27 in normal myometrium and uterine leiomyoma
tissue and its effect on cytogenic growth. Western blot analysis, real-time polymerase
chain reaction (PCR) and immunohistochemical staining revealed that p27 protein
and messenger RNA were down-regulated in uterine leiomyoma tissue and cultured
cells compared to normal myometerium. Full-length human p27 cDNA was trans-
ferred using a replication-deficient recombinant adenoviral vector (Ad.p27) into uter-
ine leiomyoma cells and evaluated the effect on cell proliferation. Transfection of
Ad.p27 into uterine leiomyoma cells resulted in the induction of apoptosis, reduc-
tion in viability and proliferation of uterine leiomyoma cells. Our results suggest a
new paradigm that down-regulated p27 protein expression is the possible underly-
ing mechanism for the growth of uterine leiomyoma and over-expression of p27
induces cell death. This study provides better understanding of the control exerted
by p27 in regulating growth and disease progression of uterine leiomyoma.
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totic, and even oncogenic functions depending on cell type
and cellular context (16). In the wake of such literature, our
primary aim was to investigate the expression of p27 in uter-
ine leiomyoma in order to identify molecular pathways that
could be important in the development of uterine leiomy-
oma. A secondary aim was to examine if regulating the expres-
sion of p27 would influence the growth of uterine leiomy-
oma, which would have direct clinical implications.
MATERIALS AND METHODS
Tissues and cell culture
Nine sets of uterine leiomyoma and their adjacent normal
myometrium tissues were obtained from hysterectomies that
were conducted on benign diseases at Dongsan Medical Cen-
ter, Daegu, Korea. No-objection written consents were ob-
tained from patients, and the study was approved by the Kei-
myung University ethical committee. We have obtained con-
sent from the patients ranging in age from 40 to 49. The stage
of their menstrual cycle was established from each woman’s
menstrual history and verified by performing a histologic exam-
ination of the endometrium. Five of the patients were in the
proliferative phase at the time of surgery and four were in the
secretory phase. Three sets of fresh uterine leiomyoma and nor-
mal myometrial tissue samples were minced and digested by
incubation in Hanks solution for 4 hr at 37℃, containing
HEPES 0.0065 g/mL, collagenase 0.0015 g/mL and DNase
0.0002 g/mL with periodic agitation. A portion of each tis-
sue was stored at -70℃for isolation of mRNA and proteins.
The dispersed uterine leiomyoma and myometrial cells were
plated in Ham F12: DMEM and grown to confluence.
Construction of recombinant ad-p27
Ad.p27 was a kind contribution from Choon-Taek Lee,
Department of Internal Medicine and Lung Institute of Med-
ical Research Center, Seoul National University, Seoul, Korea.
Construction of Ad.p27 and Ad.null is described elsewhere
(17). Briefly, the cDNA of human p27 was subcloned into the
KpnI and BamHI sites of the polylinker of adenoviral shut-
tle vector, pAC CMV pLpA. The resulting pAC CMV-27 and
pJM17 were co-transfected into 293 cells (human renal embry-
onal cells immortalized by stable transfection with E1 of
adenovirus) using the standard calcium phosphate precipita-
tion method. 293 cells were maintained in RPMI with 2%
FBS until the onset of the cytopathic effect. The generating
adenovirus was purified three times by plaque assay and con-
firmed by DNA sequencing of viral DNA and Western blot
of p27. A large-scale stock of adenovirus was prepared by
the standard CsCl method. Ad.null was a recombinant ade-
novirus without any therapeutic gene.
Immunohistochemical staining
The subcellular localization of p27 was studied using poly-
clonal antibody directed against unique sequence of p27. This
antibody was devoid of any cross-reaction with other related
proteins. Formalin-fixed and paraffin-embedded specimens
were cut into 4 mm-thick sections, deparaffinized and prein-
cubated with normal bovine serum to prevent non-specific
binding. The sections were incubated overnight at 4℃ with
primary polyclonal antibody to human p27 (Santa Cruz, CA,
U.S.A.), followed by alkaline phosphatase-conjugated goat
anti-rabbit IgG antibody (Santa Cruz). The reaction products
were visualized using a mixture of 5-bromo-4-chloro-3-indolyl
phosphate and nitroblue tetrazolium chloride (BCIP/NBT;
Roche Diagnostic Corp., Indianapolis, IN, U.S.A.). Nega-
tive controls replaced the primary antibody with non-immu-
nized rabbit serum. 
Western blot analysis
Uterine leimyoma cell extracts were prepared in lysis buffer
(10 mM Tris [pH7.4], 5 mM EDTA, 130 mM NaCl, 1% Tri-
ton X-100, PMSF [10 g/mL], leupeptin [10 g/mL], apro-
tinin [10 g/mL], 5 mM phenanthroline, and 28 mM ben-
zamidine-HCl). Protein concentrations were measured using
Bio-Rad Protein Assay Reagent (Bio-Rad, Richmond, CA,
U.S.A.) following the manufacturer’s suggested procedure.
Aliquots of protein were separated by 8-15% sodium dode-
cyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred to polyvinylidine difluoride (PVDF) mem-
brane (Millipore, Bedford, MA, U.S.A.). The membrane was
blocked with Tris-bufferd saline (TBS) with 5% skim milk
and 0.2% Tween 20, reacted with primary antibodies, and
washed. The following antibodies were used: anti-p27, anti-
Rb, anti-p21, cdk2, cdk4 and  -tubulin (Santa Cruz). After
reaction with horseradish peroxidase conjugated secondary
antibodies (Amersham Lifescience, Buckinghamshire, Eng-
land), immune complexes were visualized by using an enha-
nced chemiluminescence’s (ECL) system (Amersham Life-
science) following the manufacturer’s suggested procedure.
Cell proliferation assay
The ability of p27 to inhibit DNA synthesis was determined
by estimating the amount of BrdU incorporation into DNA
by a colorimetric immunoassay, using Cell Proliferation ELISA,
BrdU-colorimetric kit (Roche Diagnostics GmbH, Penzberg,
Germany). Uterine leiomyoma cells were cultured in 48-well
plates (1×104 cells/well). The 24-hr post-seeding cells were
transfected with Ad.p27 and Ad.null vectors, 24-hr post-
transfection the assay was carried out according to manufac-
turer’s instructions. The developed assay color was measured
at 490 nm. The color intensity and the absorbance values
directly correlate to the amount of BrdU incorporated intop27
Kip1 Controls Growth and Cell Cycle Progression in Uterine Leiomyoma 669
DNA. The results are expressed as percent inhibition of
BrdU incorporation by Ad.p27 and Ad.null vectors over
the control. Data were calculated as percentage inhibition
using the formula: 
Inhibition (%)=(100-(ODt/ODs)×100
Where ODt and ODs are the optical density of the test sub-
stance and solvent control, respectively.
Fluorescence-activated cell sorting (FACS) analysis
To determine the cell cycle distribution, FACS analysis was
done in uterine leiomyoma cells transfected with Ad.p27 and
Ad.null vectors. Twenty-four hours after transfection, cells
were harvested, washed with PBS, and fixed in cold 70%
ethanol. Fixed cells were suspended in 0.1% RNase A and
propidium iodide (50  g/mL in PBS) to determine cell cycle
dynamics. DNA fluorescence was measured by flow cytometer
(FACS CaliburTM, Becton Dickinson, Franklin Lakes, NJ,
U.S.A.). The percentage of cells in each cell cycle phase was
determined using the ModFit LTTM software (Becton-Dick-
inson) based on the DNA histogram.
Statistical evaluation
Data are expressed as means±SD for all experiments. Stu-
dent-t test was used to assess statistical significance between
means. p<0.05 was considered significant.
RESULTS
Down-regulation of p27 in human uterine leiomyoma
tissues and cultured cells
The expression levels of p27 protein and mRNA in human
normal myometrium and uterine leiomyoma tissues were
examined by Western blot analysis and semi-quantitative real-
time RT-PCR analysis, respectively. We found a significant
decrease in p27 protein expression levels in uterine leiomy-
oma tissue samples (Fig. 1), which paralleled data from cul-
tured uterine leiomyoma tissues as well (Fig. 2). Comparison
of immunohistochemical staining for p27 protein in forma-
lin-fixed paraffin-embedded sections of leiomyoma (LM) and
myometrial tissues (NM) revealed that myometrial smooth
muscle cells showed more predominant immunostaining
for p27 protein than uterine leiomyoma cells. Cytoplasmic
and nuclear brown-staining cells are positive for p27 pro-
tein expression (Fig. 3). To determine whether the altered
Fig. 1. Decreased p27 protein expression levels in human uterine
leiomyoma tissue.Total protein was isolated from uterine leiomy-
oma and normal myometrial tissues. Nine pairs of tumor and nor-
mal tissues; i.e., each pair of samples was obtained from same
patient - M; uterine leiomyoma, N; normal myometrium, 5 of the tis-
sue samples belonged to the proliferative phase (#1 to #5) and
the rest to the secretory phase (#6 to #9). Fifty micrograms of the
total isolated protein were resolved by SDS-polyacrylamide gel
electrophoresis and electroblotted onto PVDF membranes. The
blot was incubated with antibody against p27. Reactive bands
were visualized with an ECL labeling and detection system.  -
tubulin was used as the loading control. Densitometric analysis
was also done to the western blots to determine the relative pro-
tein expression levels. 
R
e
l
a
t
i
v
e
 
p
2
7
k
i
p
1
p
r
o
t
e
i
n
e
x
p
r
e
s
s
i
o
n
2.5
2
1.5
1
0.5
#1 #2 #3 #4 #5 #6 #7 #8 #9
MN MNMNMN MNMNMNMN MN
Paired uterine leiomyoma and normal myometrium tissue samples
p27
kip1
-tubulin
Fig. 2. Decreased p27 protein expression levels in cultured human
uterine leiomyoma tissue. Total protein was isolated from cultured,
well-grown, confluent uterine leiomyoma and normal myometrium
tissue samples (3 pairs of tumor and normal tissue, obtained from
same patient - M; uterine leiomyoma, N; normal myometrium, 2 of
the cultured cells were from proliferative phase tissue samples (#1
and #2) and #3 was cultured cells of the secretory phase tissue
sample). Fifty micrograms of the total isolated protein were resolved
by SDS-polyacrylamide gel electrophoresis and electroblotted
onto PVDF membranes. The blot was incubated with antibody
against p27. Reactive bands were visualized with an ECL label-
ing and detection system.  -tubulin was used as the loading con-
trol. Densitometric analysis was also done to the Western blots to
determine the relative protein expression levels. 
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expression in p27 protein level reflects changes in its mRNA
level, real-time PCR analysis for p27 expression was per-
formed in pairs of uterine leiomyoma and corresponding
myometrium (Fig. 4). The results were in concordance with
the observation with p27 protein expression. 
Confirmation of adenoviral expression of p27
1 in uterine
leiomyoma cells
The expression of p27 protein following Ad.p27 infection
was confirmed by Western blot (Fig. 5). Fig. 5 shows that
ectopic expression of p27 (mediated through infection with
recombinant adenovirus Ad.p27) mRNA in uterine leiomy-
oma cells. To gain insight into the cell-cycle status of p27-
transfected cells, we examined the phosphorylation pattern
of Rb protein, p21, cdk2 and cdk4. Ad.p27-transfected myoma
cells show principally hypophosphorylated Rb attributing
to their slow-dividing nature. No such effect was observed
with Ad.null infected cells (Fig. 5).
Adenoviral expression of p27 in uterine leiomyoma cells
inhibits cell proliferation
Because p27 is an important control mechanism of the cell
cycle, we studied the effects of expression of Ad.p27 on uter-
ine leiomyoma cell proliferation. The proliferation rate of uter-
ine leiomyoma cells transfected with empty adenovirus (which
does not carry the recombinant gene-Ad.null) was indistin-
guishable from that of untransfected cells (Control cells). In
contrast, the rate of proliferation of cells in which Ad.p27 was
expressed was 40-50% lower than that observed in uterine
leiomyoma cells infected with an equal amount of the empty
adenovirus (Ad.null) (Fig. 6).
Expression of p27 in uterine leiomyoma cells causes cell
death and increased cells in subG1 phase 
To investigate the mechanism by which expression of p27
inhibits uterine leiomyoma cell proliferation, we performed
cell cycle analysis. Uterine leiomyoma cells transfected with
empty adenovirus (Ad.null) showed almost similar patterns
Fig. 3. Comparison of immunohistochemical staining for p27 protein. Immunohistochemical staining for p27 formalin-fixed paraffin-embed-
ded sections of uterine leiomyoma (LM) and myometrial tissues (NM). (A) Myometrial smooth muscle cells showed more predominant immunos-
taining for p27 protein than the leiomyoma cells (magnification ×40), (B). Normal myometrial cells showed positive for p27 protein (mag-
nification ×100), (C). Leiomyoma cells showed negative for p27 protein (magnification ×100), (D). Cytoplasmic and nuclear brown-stain-
ing cells are positive for p27 protein expression (magnification ×400). 
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and timing of progression through the different phases of the
cell cycle that were indistinguishable from cells that were
not transfected with the adenovirus (Control cells), whereas
Ad.p27 transfected uterine leiomyoma cells had a surging
increase in sub-G1 population of cells (Fig. 7). The increase
in sub-G1 peak can be attributed to cells that became arrest-
ed at G1 phase which was confirmed by the appearance of
hypophosphorylated Rb specific to G1 phase (Fig. 5) and the
lack of BrdU incorporation (Fig. 6).
DISCUSSION
The transition from G1 to S is controlled by the concerted
actions of protein kinases, the activities of which are modu-
lated by families of regulatory proteins in both a positive
(cyclins) and a negative (cyclin-dependent kinase inhibitors
[CKI]) manner. A family of CKI plays a major role in the cell
cycle machinery (18). Among them, p27 is thought to repre-
sent the most bona fide inhibitor as its level oscillates through-
Fig. 4. Decreased p27 mRNA levels in human uterine leiomyoma
tissue. Total RNA was isolated from uterine leiomyoma and nor-
mal myometrial tissues (4 pairs of tumor and normal tissues; i.e.,
each pair of samples was obtained from same patient; tissue sam-
ples #1 and #2 were isolated at the proliferative phase and tissue
samples #3 and #4 were isolated at the secretory phases of the
menstrual cycle). cDNA templates for RT were prepared from the
total RNA extracted. The level of p27 mRNA was determined by
quantitative real-time PCR. Relative p27  mRNA levels (normalized
to GAPDH) in paired samples represented as M; uterine leiomy-
oma, N; normal myometrium. *, p<0.05; **, p<0.01.
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Fig. 5. Effect of Ad.p27 transfection on uterine leiomyoma cells. Cul-
tured uterine leiomyoma cells were transfected with Ad.null and
Ad.p27 recombinant, non-replicating adenoviral vectors. Twenty-
four hours after transfection, immunoblotting was performed to
detect the expression levels of p27, p21, Rb, cdk2 and cdk4.  -
tubulin was used as the loading control. Transfection of Ad.p27
onto uterine leiomyoma cells caused increased expression levels
of p27 and dephosphorylation of Rb.
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Fig. 6. Inhibition of the synthesis of DNA in uterine leiomyoma cells
by Ad.p27. The antiproliferative effects were determined after trans-
fecting uterine leiomyoma cells for 24 hr with Ad.null and Ad.p27
adenoviral vectors and labeling with BrdU (10  M) for 24 hr. Results
are expressed as percentage inhibition of BrdU incorporation rel-
ative to control cells. Values are the means (±SD) of three exper-
iments with triplicate determinations. *, p<0.05; **, p<0.01.
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Fig. 7. Effect of Ad.p27 on the cell cycle profile. Ad.null and Ad.p27
transfected uterine leiomyoma cells were harvested, fixed, stained
with PI, and analyzed by flow cytometry analysis. The values rep-
resent the number of cells in each phase of the cell cycle as a per-
centage (%) of total cells. Following transfection with Ad.p27, the
growth of uterine leiomyoma cells was affected with an increase in
the percentage of cells in the sub-G1 phase.
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out the cell cycle with the highest level observed during G1
and the lowest during S and G2/M phases. p27 is frequently
inactivated in tumorigenic cells, and is considered to be a
potent tumor suppressor.
High-level expression of p27 was detected in some highly
proliferative breast cancer and colorectal cells (19). This evi-
dence seems to provide a novel aspect of the role of p27 in
cancer cells because an inverse correlation between p27 expres-
sion and cell proliferation is generally observed in normal
human tissues. It has been reported that a subset (35%) of
colorectal carcinomas displayed diffuse cytoplasmic staining
for p27 by immunohistochemical staining (20). Cytoplasmic
localization of p27 was associated with decreased survival in
Barrett’s associated adenocarcinoma (21), suggesting that the
subcellular localization of p27 may be an adverse prognostic
factor. Recent reports claim decreased p27 expression in cer-
vical (22), lung cancer (23), and prostate (24). Histological
staining analysis of p27 in uterine leiomyoma and leiomyosar-
coma showed that p27 as a significant prognostic indicator
(14). The biological behavior of p27 may be somewhat com-
plex in some types of cancer cells, and comprehensive analy-
ses of the p27 status should be performed to precisely assess
the clinical value of p27.
To date, the prognosis of uterine leiomyoma patients has
remained poor, and identification of useful molecular prog-
nostic marker for this clinical condition is required. Because
deregulated cell-cycle progression is one of the most signifi-
cant alterations in cancer cells, many studies have investigat-
ed cell-cycle regulators. To comprehensively investigate the
biological significance of p27 in uterine leiomyoma, we thor-
oughly examined the p27 status in primary tumors. Our im-
munohistochemical staining results revealed that myometrial
smooth muscle cells showed more predominant p27 stain-
ing when compared to uterine leiomyoma cells. To compare
protein expression levels in uterine leiomyoma and myome-
trial tissues and to confirm the results of immunohistochem-
ical staining, immunoblotting analysis was performed using
lysates obtained from available paired normal/tumor tissue
samples. The level of p27 protein expression correlated with
results determined by immunohistochemistry. The detectable
levels of expression in myometrial tissues seem to be attributable
to the expression in various kinds of cells as observed in imm-
unohistochemistry. Western blotting and real-time PCR anal-
ysis revealed remarkable correlation of p27 expression with
uterine leiomyoma formation.
Controlled proliferation and differentiation of uterine leiomy-
oma cells plays an important role in leiomyoma development.
Therefore, demonstrating the mechanism of uterine leiomy-
oma cell proliferation not only helps us to understand leiomy-
oma development, but it could also lead to a strategy to reg-
ulate its development. In this work we utilized the adenovi-
ral mediated expression of p27 in uterine leiomyoma cells
and demonstrated that the p27 does play an important role
in the control of leiomyoma cell cycle.
The CKI p27, once activated, have been shown to phos-
phorylate various substrates (25), including the retinoblas-
toma tumor suppressor gene product. pRb negatively regu-
lates the cell cycle when hypophosphorylated during G0 and
early Gl, and pRb is progressively phosphorylated during mid
to late Gl (26). In this hypophosphorylated state, pRb func-
tions as a transcriptional repressor. To gain an insight into
the cell cycle status of Ad.p27 transfected uterine leiomyoma
cells, we initially examined the phosphorylation pattern of
endogenous Rb protein. Western blot analysis of control and
Ad.null transfected uterine leiomyoma cells showed both
hyperphosphorylated and unphosphorylated forms of Rb pro-
tein, indicative of cells progressing through the cell cycle. In
contrast, Ad.p27 transfected cells show principally hypophos-
phorylated Rb that possibly attributes to the slow-dividing
nature of these cells. These data unequivocally demonstrate
that p27 expression plays an important role in controlling
cell cycle regulators and the proliferation of uterine leiomy-
oma cells.
If hyperploid progression occurs through continued cell
cycling without cell division, then one should be able to block
it by expressing G1-specific CKI’s. p27 is an inhibitor of cyclin-
dependent kinases cdk4 and cdk6 controlling passage through
early G1, as well as cdk2 controlling progression through late
G1 phase (27). Our results show that ectopic expression of
p27 in uterine leiomyoma cells resulted in the absence of a
hyperploid peak along with an increase in the G2/M peak.
The increase in the G2/M peak is due to cells that have tra-
versed through M phase, but most cells were arrested at G1
phase, which was confirmed by the appearance of unphospho-
rylated Rb specific to G1 phase. This was further validated
with our results from the BrdU assay. To observe DNA syn-
thesis at a single-cell level, BrdU incorporation assay was per-
formed. Reduced DNA synthesis in the presence of Ad.p27
in uterine leiomyoma cells emphasizes the repressor activity
of p27.
The p27 is a nodal factor controlling normal cell cycle. Its
expression in normal myometrium raised the question whether
it has a mutual exclusive or redundant role in uterine leiomy-
oma. The possible reason for the suppressed expression of
p27 in uterine leiomyoma is thought to be the role played
by hormones. Estrogen plays a pivotal role in the prolifera-
tion of uterine leiomyoma cells and the role of estrogen in
suppressing p27 expression have been elucidated in endome-
trial cancer tissues (10) and this role of estrogen could also
be attributed to uterine leiomyoma. Further studies are required
to elucidate the correlated role between estrogen and p27 in
uterine leiomyoma. Results from our comparative compre-
hensive analysis in a series of uterine leiomyoma tissues and
p27 over expression studies reveal that this cell cycle regula-
tory protein acts as a checkpoint in uterine leiomyoma growth
and development. This provides a unique opportunity to devel-
op a therapy that is specific against tumors lacking the G1
checkpoint. By exploiting the hyperploid-progression-medi-p27
Kip1 Controls Growth and Cell Cycle Progression in Uterine Leiomyoma 673
ated death, a therapy that is tumor specific at the genetic level
may be developed and it may have a wide therapeutic appli-
cability in clinical management of uterine leiomyoma.
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